Fig. 2From: Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinomaKaplan–Meier survival curves of PFS and OS in the training cohort. a shows the curves based on LA groups for PFS; b shows the curves based on LA groups for OS; c shows the curves based on EBV DNA groups for PFS; d shows the curves based on EBV DNA groups for OS. Worse prognosis was observed in patients with low LA or positive EBV DNABack to article page